Acknowledgement
5 Business Days
EA Therapies for Single Patient

CPO301

EA Policies for Single Patient

Eligibility Criteria:
To be eligible for Expanded Access, patients must meet the following criteria:
• Have a serious or life-threatening condition for which no satisfactory alternative treatments are available.
• Be unable to participate in ongoing clinical trials.
• There is sufficient clinical data available with respect to both the investigational drug and the disease condition for which the application is being sought, to anticipate that any potential benefits from treatment are likely to outweigh any potential risks to the patient.
• Conjupro must have an adequate supply of the investigational drug.